K Meijer, E B Haagsma, J van der Meer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAntiviral Agents/administration & dosageBlood Coagulation Disorders/complicationsDouble-Blind MethodDrug Therapy, CombinationHemophilia A/complicationsHepatitis C, Chronic/complicationsHepatitis C, Chronic/drug therapyHepatitis C, Chronic/virologyHumansInterferon alpha-2Interferon-alpha/administration & dosageMiddle AgedRecombinant ProteinsRibavirin/administration & dosage
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsRibavirin
Year: 2004 PMID: 14717986 DOI: 10.1111/j.1538-7836.2004.0562c.x
Source DB: PubMed Journal: J Thromb Haemost ISSN: 1538-7836 Impact factor: 5.824